| Micro-channel |
 |
|
|
|
|
|
| |
| Chinese pharmaceutical companies research and develop, these 50 strongest! |
| |
| Author：中国铭铉 企划部 Release Time：2017-9-18 11:00:50 Number Browse：1019 |
| |
Medical network - on September 18, recently, jointly organized by drug intelligence network, China pharmacy magazine of 2017 Chinese medicine theory of innovation summit held in chongqing, solemnly announced at the meeting the list of "2017 Chinese medicine research and development strength, let's take a look at this list:
2017 China pharmaceutical enterprise r&d strength list
|
排名
|
公司名称
|
|
1
|
正大天晴药业集团股份有限公司
|
|
2
|
齐鲁制药有限公司
|
|
3
|
江苏恒瑞医药股份有限公司
|
|
4
|
上海复星医药（集团）股份有限公司
|
|
5
|
浙江海正药业股份有限公司
|
|
6
|
江苏豪森药业集团有限公司
|
|
7
|
东阳光药业
|
|
8
|
四川科伦药业股份有限公司
|
|
9
|
山东罗欣药业集团股份有限公司
|
|
10
|
扬子江药业集团有限公司
|
|
11
|
南京华威医药科技集团有限公司
|
|
12
|
石药集团有限公司
|
|
13
|
上海医药集团股份有限公司
|
|
14
|
浙江华海药业股份有限公司
|
|
15
|
四环医药控股集团有限公司
|
|
16
|
江苏奥赛康药业股份有限公司
|
|
17
|
瑞阳制药有限公司
|
|
18
|
丽珠医药集团股份有限公司
|
|
19
|
人福医药集团股份公司
|
|
20
|
中国医学科学院药物研究所
|
|
21
|
天士力制药集团股份有限公司
|
|
22
|
健康元药业集团股份有限公司
|
|
23
|
江苏康缘药业股份有限公司
|
|
24
|
山东步长制药股份有限公司
|
|
25
|
海思科医药集团股份有限公司
|
|
26
|
天津市医药集团有限公司
|
|
27
|
云南沃森生物技术股份有限公司
|
|
28
|
中国人民解放军军事医学科学院毒物药物研究所
|
|
29
|
江西施美药业股份有限公司
|
|
30
|
南京海纳医药科技股份有限公司
|
|
31
|
青峰医药集团有限公司
|
|
32
|
辰欣药业股份有限公司
|
|
33
|
百济神州
|
|
34
|
先声药业有限公司
|
|
35
|
哈尔滨誉衡药业股份有限公司
|
|
36
|
中国科学院上海药物研究所
|
|
37
|
成都苑东生物制药股份有限公司
|
|
38
|
天津市汉康医药生物技术有限公司
|
|
39
|
济南百诺医药科技开发有限公司
|
|
40
|
上海现代制药股份有限公司
|
|
41
|
华邦生命健康股份有限公司
|
|
42
|
鲁南制药集团股份有限公司
|
|
43
|
四川百利药业有限责任公司
|
|
44
|
深圳信立泰药业股份有限公司
|
|
45
|
信达生物制药（苏州）有限公司
|
|
46
|
石家庄以岭药业股份有限公司
|
|
47
|
浙江医药股份有限公司
|
|
48
|
贝达药业股份有限公司
|
|
49
|
华东医药股份有限公司
|
|
50
|
北京康立生医药技术开发有限公司
|
In addition to this list, there are "top 50" list of "2017 Chinese medicine r&d strength", which includes pharmaceutical companies' key concerns.
It is pointed out that chemical medicine has been the core of the research and development of pharmaceutical companies in China, and the research and development degree is much higher than that of traditional Chinese medicine and biological medicine, so this is also the field of pharmaceutical enterprises. According to drug intelligence data statistics, in 2000-2017 (as of September 1) accept the medicine a total of 118763, accounting for 71.84% of the total acceptance number, including medicine new medicine 36415, accounted for 30.66%, thus it can be seen that the medicine has been the highlight of pharmaceutical research, prospects.
Since our entry into the wto, innovative drugs have sprung up frequently. But there are few new drugs in the country that are truly internationally recognized. Most are generic drugs, and fewer are independently developed.
Some people in the industry say that more than 80% of the sales of foreign drugs can return to production enterprises, providing adequate financial support for further research and development. Some large multinational pharmaceutical companies spend between 10% and 20% of their profits on research and development. In our country, only a small percentage of product sales can return to the production enterprise, some only 10% ~ 20%.
In the past, many drug companies focused on marketing rather than research and development. Faced with huge cost of new drug research and development, combined with the new drug research and development cycle is long, high risk, many drug companies no desire to get new drug research and development, but more in marketing, in order to beat the competition in the market, thus neglected the development process.
In recent years, relevant departments of the state are encouraging the innovation and development of drug companies in new drugs, which undoubtedly gives the domestic pharmaceutical companies an opportunity to develop new drugs. Therefore, many pharmaceutical companies have gradually changed the concept of "resale and light development", and began to pay more attention to the development of enterprises, thus promoting the development of the whole pharmaceutical industry.
Under the efforts of major drug companies over the past year, with the release of "top 50 of China's r&d strength of 2017", the list of the most powerful pharmaceutical companies in 2017 has been settled and the list of drug companies listed on the list is well deserved.
Here are the top 50 pharmaceutical companies listed in China in 2017.
Top 50 of China's pharmaceutical r&d strength in 2017
|
| |
Previous article：The "flying inspection" + centralized control of 93 pharmaceutical companies in the six provinces were examined
Next article：Chinese pharmaceutical companies research and develop, these 50 strongest!
|
| |
|
|
